BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7403228)

  • 1. The inhibitory effect of pyrazinamide on microsomal monooxygenase activities is related to the binding to reduced cytochrome P-450.
    Maffei Facino R; Carini M
    Pharmacol Res Commun; 1980 Jun; 12(6):523-37. PubMed ID: 7403228
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed type hepatic microsomal enzyme induction by hexachlorobenzene.
    Stonard MD
    Biochem Pharmacol; 1975 Nov; 24(21):1959-63. PubMed ID: 1212246
    [No Abstract]   [Full Text] [Related]  

  • 3. A reevaluation of the role of cytochrome P-450 as the terminal oxidase in hepatic microsomal mixed function oxidase catalyzed reactions.
    Cooper DY; Schleyer H; Levin SS; Eisenhardt RH; Novack BG; Rosenthal O
    Drug Metab Rev; 1979; 10(2):153-85. PubMed ID: 399457
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.
    Facino RM; Lanzani R
    Pharmacol Res Commun; 1979 May; 11(5):433-45. PubMed ID: 39298
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cadmium on microsomal hemoproteins and heme oxygenase in rat liver.
    Krasny HC; Holbrook DJ
    Mol Pharmacol; 1977 Jul; 13(4):759-65. PubMed ID: 887078
    [No Abstract]   [Full Text] [Related]  

  • 6. On the possible in vitro use of perfluoro compounds as oxygen reservoir for the microsomal monooxygenase system.
    Brown NA; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2850-2. PubMed ID: 115475
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of various types of inducing agents on hepatic microsomal monooxygenase activity in rainbow trout.
    Vodicnik MJ; Elcombe CR; Lech JJ
    Toxicol Appl Pharmacol; 1981 Jun; 59(2):364-74. PubMed ID: 7256774
    [No Abstract]   [Full Text] [Related]  

  • 8. Microsomal mixed function oxidases in an estuarine fish, Fundulus heteroclitus, and their induction as a result of environmental contamination.
    Burns KA
    Comp Biochem Physiol B; 1976; 53(4):443-6. PubMed ID: 1261232
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of the liver microsomal drug-metabolizing enzyme system of newborn rats.
    Iba MM; Soyka LF; Schulman MP
    Mol Pharmacol; 1977 Nov; 13(6):1092-104. PubMed ID: 22806
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of aging and induction of rat liver and kidney microsomal mixed function oxidase systems.
    McMartin DN; O'Connor JA; Fasco MJ; Kaminsky LS
    Toxicol Appl Pharmacol; 1980 Jul; 54(3):411-9. PubMed ID: 7394797
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible mechanism of carbon disulphide hepatotoxicity [proceedings].
    Obrebska MJ; Parke DV
    Biochem Soc Trans; 1980 Feb; 8(1):97-8. PubMed ID: 6768619
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of DDT on hepatic microsomal drug-metabolising enzymes in the baboon: comparison with the rat.
    Down WH; Chasseaud LF
    Bull Environ Contam Toxicol; 1978 Nov; 20(5):592-601. PubMed ID: 104750
    [No Abstract]   [Full Text] [Related]  

  • 13. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats. A comparative study.
    Dent JG; Graichen ME; Schnell S; Lasker J
    Toxicol Appl Pharmacol; 1980 Jan; 52(1):45-53. PubMed ID: 6767296
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of nitrofuran derivatives on hepatic microsomal mixed-function oxidase activity in rats.
    Fukuhara M; Takabatake E
    Toxicol Appl Pharmacol; 1977 Dec; 42(3):571-81. PubMed ID: 601798
    [No Abstract]   [Full Text] [Related]  

  • 15. Developmental aspects of the hepatic cytochrome P450 monooxygenase system.
    Neims AH; Warner M; Loughnan PM; Aranda JV
    Annu Rev Pharmacol Toxicol; 1976; 16():427-45. PubMed ID: 820239
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and gonadectomized-diabetic rats.
    Al-Turk WA; Stohs SJ; Roche EB
    Gen Pharmacol; 1981; 12(5):345-50. PubMed ID: 7286602
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectral changes in liver microsomal cytochrome P-450 from benzanthracene-treated normal and partially hepatectomized rats.
    Fischer PW; Spencer T
    Chem Biol Interact; 1974 Apr; 8(4):253-9. PubMed ID: 4830506
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycemic (ob/ob and db/db) and lean streptozotocin-treated mice.
    Rouer E; Leroux JP
    Biochem Pharmacol; 1980 Jul; 29(13):1959-62. PubMed ID: 7397002
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinamide administration alters the activities of hepatic microsomal mixed function oxidases.
    Batra JK; Raj HG; Venkitasubramanian TA
    Experientia; 1980 Nov; 36(11):1311. PubMed ID: 6450052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.